Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2024-08-08 00:00:00 ET · period of report 2024-08-07 · accession 0000875320-24-000202 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-08 | 2024-08-07 | VRTX | Bozic Carmen | EVP, CMO | S - Sale | $476.75 | -2,280 | 23.3K | -9% | -$1.09M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-07 | S | D | 2,280 | $476.75 | 23,259 | D | — | — |